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Abstract 
The growing use of cochlear prosthetic devices and demonstrations of direct ototoxic insult to spiral ganglion neurons make it 
imperative to gain an understanding of intracellular biochemical regulation in primary sensory neurons. Calcium and calmodulin 
regulate many aspects of neuronal cellular physiology through stimulation of protein kinase activity. We have previously 
demonstrated the presence of calmodulin-dependent protein kinase substrates in the guinea pig modiolus and, additionally, the 
presence of two proteins (12 kDa and 81 kDa, designated as ~12 and ~81) whose phosphorylation is blocked by calcium and 
calmodulin (Coling and Schacht, 1991). Here, we investigate three models for this unusual regulatory mechanism. The effects of 
calcium, calmodulin and trifluoperazine on dephosphorylation of both proteins suggests that calmodulin inhibits protein kinasc 
activity. PSl was identified by immunoprecipitation as the myristoylated alanine-rich C kinase substrate (MARCKS), a 
ubiquitous actin-binding protein. Two observations indicate that MARCKS may be regulated differently in acoustic nerve than in 
cerebral cortex. “P incorporation was significantly higher in acoustic nerve than in brain. The calmodulin-dependent block of 
MARCKS phosphorylation was observed only in acoustic nerve. p12 shares several characteristics with myelin basic protein 
(MBP). We used a double label assay with 32P autoradiography and immunoblotting to show that p12 is in fact distinct from 
MBP. We suggest that either p12 or p12 kinase may be either specific to the peripheral auditory system or novel marker proteins 
for that tissue. 
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Protein phosphotylation 
1. Introduction 
The primary sensory neurons of the spiral ganglion 
form an integral link in the auditory pathway. Atrophy 
and demyelination of spiral ganglion cells and their 
processes can occur in response to aging, ototoxic 
drugs, acoustic overstimulation and certain hereditary 
diseases (Mustillo, 1984; Schwartz 1986; DuPont et al., 
1993). Our understanding of the molecular events un- 
derlying acoustic nerve physiology and pathology was 
initiated by Wenthold and colleagues with their studies 
of changes in axonal transport of proteins in response 
to noise stimuli (Tytell et al., 1980; Wenthold and 
McGarvey, 1982a,b). More recently, Van De Water 
and associates have reported experiments on the influ- 
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ence of trophic factors on the survival of isolated spiral 
ganglion neurons (Lefebvre et al., 1992a,b). 
There is no information on intracellular mechanisms 
that regulate auditory nerve biochemistry. We antici- 
pate that protein phosphorylation will play a major role 
in this regulation as is the case in most other tissues. In 
other neuronal tissue, for example, protein phosphory- 
lation provides major effector systems for control of 
cellular physiology and homeostasis (for review, see 
Nestler and Greengard, 1984; Nairn et al., 1985; Co- 
hen, 1989). 
Phosphate incorporation into proteins by protein 
kinases and its removal by protein phosphatases consti- 
tutes a molecular switch which can dramatically alter 
the structure and hence function of protein substrates. 
Kinase and phosphatase activities are regulated by 
ligand binding to extracellular receptors and by binding 
of a variety of second messengers to intracellular effec- 
tor enzymes. Of the latter, calcium and calmodulin-de- 
pendent protein kinase activity appears to be a particu- 
larly widely used system in the neural tissues of the 
cochlea (Coling and Schacht, 1991). We reported two 
auditory nerve proteins that exhibited a very unusual 
type of calcium and calmodulin-dependent regulation 
of protein phosphorylation. 32P incorporation in the 
two proteins, 81 and 12 kDa (designated here as p81 
and ~121, was almost completely blocked in the pres- 
ence of calcium and calmodulin (Coling and Schacht, 
19911. 
Calcium and calmodulin form a second messenger 
complex which regulates protein phosphorylation as 
well as a variety of other important cellular reactions. 
In most reported cases, this regulation is mediated by 
stimulating calcium/ calmodulin-dependent protein ki- 
nases (reviewed in Nairn, 198.5) or protein phosphatase 
2B (calcineurin; Stewart et al., 1982). Another mode of 
action of calmodulin is suggested by recent experi- 
ments on the myristoylated alanine-rich C kinase sub- 
strate (MARCKS, ‘87 kDa’; Wu et al., 1982; Albert et 
al., 1984; Graff et al., 1989). Here, an inhibition of 
protein kinase activity appears to result from binding 
of the calcium/calmodulin complex at or near the 
closely spaced phosphorylation sites on the protein 
substrate (Graff et al., 1989; Tokumitsu et al., 19891. 
Phosphorylation of neuromodulin (GAP43, B50, ~57, 
Fl; Houbre et al., 1991) may be similarly regulated. 
In this communication, we provide evidence that the 
calcium/calmodulin regulation of p81 and p12 is at 
the level of inhibition of the respective protein kinases. 
We identify p81 as the actin-binding protein, MAR- 
CKS. We also provide data which strongly suggests that 
p12 is a novel member of the small family of proteins 
whose phosphorylation is inhibited by calcium and 
calmodulin. 
2. Materials and methods 
2.1. Tissue preparation 
The modiolus with the spiral ganglion was removed 
from the inner ears of pigmented guinea pigs (250-400 
g) as described (Coling and Schacht, 1991). In some 
experiments, the nerve fiber core was dissected from 
the modiolus in order to eliminate surrounding bony 
tissue. After dissection, the tissue was washed and 
sonicated (Cole Parmer 4710, 2 mm tip) 4 times, 3 s 
each, in homogenization buffer (10 mM sodium 4-(2- 
hydroxyethyl)-1-piperazineethanesulfonic acid (HE- 
PES), pH 7.4, 10 mM MgCl,, 0.2 mM [ethylenebis 
(oxyethylenenitrilojltetraacetic acid (EGTA) with 200 
PM phenylmethylsulfonyl fluoride, 2 ,uM pepstatin A 
and 2 PM leupeptin as protease inhibitors). 
2.2. Endogenous kinase ~~ss~ys 
Labeling was initiated by adding 7.5 PM [y-7”P]ATP 
(Amersham, spec. activity 1.06 fBq/mol) to 1 to 5 gg 
protein in homogenization buffer (Coling and Schacht. 
1991). When indicated, 0.6 mM CaCl?, 10 PM calmod- 
ulin (Sigma, St. Louis, MO), 30 PM trifluoperazine, 1 
PM cyclic nucleotides, lipids (100 pg/ml phos- 
phatidylserine and 10 pg/ml 1,2-diolein) or combina- 
tions of these agents were added. Incubations were 
terminated by the addition of ‘stop’ buffer (final con- 
centrations, 62.5 mM Tris-HCl, pH 6.8, 2% SDS, 10% 
glycerol, 5% 2-mercaptoethanol, 0.003% bromophenol 
blue) and boiling for 5 min. 
2.3, Chase assays 
Homogenates with 1 to 5 pg protein in 25 ~1 of 
homogenization buffer were preincubated without ra- 
dioactivity for 10 to 45 min at room temperature and 
then labeled for 30 s with 10.5 PM [Y-~*P]ATP (spec. 
activity 1.5 fBq/mol). The preincubation period as- 
sured a reproducible incorporation of radioactivity in 
the brief labeling period presumably by establishing a 
steady-state of dephosphorylated substrates. The 
‘chase’ was initiated by the addition of unlabeled ATP 
(final concentration 7.5 mM) plus or minus 10 mM 
CaCl,, 10 PM calmodulin, or 100 PM trifluoperazine. 
The incubation was terminated as described above. 
2.4. Electrophoresis and 32P detection 
Proteins were separated by SDS-polyacrylamide gel 
electrophoresis (SDS-PAGE, Laemmli, 1970) on 3 to 
20% acrylamide gradient gels and phosphoproteins vi- 
sualized by autoradiography. Molecular weight was es- 
timated from protein standards by second order poly- 
nomial regression. Incorporation of 32P was quanti- 
tated by liquid scintillation counting of bands cut from 
dried gels. Changes in phosphorylation are reported as 
percent of control f standard error. Control and exper- 
imental samples differed only by the addition of the 
second messenger or inhibitor. Control and experimen- 
tal values were evaluated by one-tailed paired t-tests. 
A level of P < 0.05 was chosen to indicate a significant 
difference. 
2.5. Protein determination 
Cold 5% trichloroacetic acid in acetone ( - 2o”C, 0.5 
ml) was added to 20 ~1 of homogenate. After 10 to 30 
min at 4”, the suspension was centrifuged (5 min at 
14,000 x g) and the supemate aspirated. The remain- 
ing pellet was resuspended by sonication in 100 ~1 of 
1% SDS. Insoluble residue was cleared by centrifuga- 
tion (5 min at 14,000 x g>, and the final supernate 
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assayed for total protein using a bicinchoninic acid 
protein assay (Pierce, Rockford, IL; Smith et al., 1985). 
2.6, Immunoprecipita tion 
Auditory nerve tissue (modiolus with nerve fiber 
core, 10 pg) or temporal cortex (20 kg) were labeled as 
described for endogenous kinase assays and reactions 
were terminated by boiling in 0.5% SDS for 5 min. 
Immunoprecipitation was carried out according to 
Nestler and Greengard (1980). Staphylococcus aureus 
cells (Boehringer-Mannheim Biochemicals, Indianapo- 
lis IN) were used to precipitate immune complexes 
formed by overnight incubation of precleared ho- 
mogenate fractions with 10 ,ul of either normal rabbit 
or rabbit anti-rat brain MARCKS serum (gift from 
Drs. Angus Nairn, Katherine Albert, James K.-T. Wang 
and Paul Greengard). 
2.7. Phosphoamino acid analysis 
The modiolus and acoustic nerve core from two 
cochleae were labeled with [Y-~*P]ATP in low calcium 
(EGTA) as described above for endogenous kinase 
labeling. To ensure sufficient 32P incorporation for 
subsequent steps, specific radioactivity was increased 
by a factor of 10 for these experiments. p12 was gel 
purified by preparative electrophoresis on a 5-18% 
gradient slab gel. The p12 band was identified on the 
unstained dried gel by alignment with the correspond- 
ing autoradiograph and cut from the gel. p12 was 
extracted by incubation in 50 ml ammonium carbonate 
(0.05 M ammonium bicarbonate, 0.05 M ammonium 
hydroxide) for 24 h at 37°C and concentrated by 
lyophilization, resuspension in 98% formic acid and 
repeated lyophilization. Hydrolysis was carried out at 
120°C in 6 N HCl for either 90 min under house 
vacuum or an additional 4 h under high vacuum (2 pm 
Hg). Hydrolysates were lyophilized and amino acids 
were separated in two dimensions; first by elec- 
trophoresis and second by thin layer chromatography 
as described by Stratford et al. (1984). For improved 
resolution of phosphotyrosine and phosphothreonine, 
the chromatographic separation was repeated on the 
same plate. Phosphoamino acid standards (Sigma 
Chemical Co., St. Louis) were stained by spraying the 
plates with 0.1% ninhydrin in acetone. 32P amino acids 
were detected by autoradiography. 
2.8. Double label, “2P/immunoblotting 
Tissue homogenates were labeled with [Y-~~P ATP] 
as described for endogenous kinase assays. Biotiny- 
lated protein standards were purchased from BioRad 
(Richmond, CA). Control experiments confirmed that 
these standard proteins comigrated with unmodified 
standards (Sigma, St. Louis) used in previous molecular 
weight assignments. Proteins separated by SDS-PAGE 
were transferred to polyvinylidene difluoride (PVDF, 
Immobilon-P, Millipore, Bedford, MA) on a semi-dry 
transfer apparatus (Hoefer TE-77, San Francisco, CA) 
for 1 h at 0.8 mA/cm’ using the buffer system de- 
scribed by Towbin et al. (1979). In control experiments 
a sheet of PVDF was placed on the cathode side of the 
gel during transfer and two sheets of PVDF were 
placed on the side of the anode to check for the 
migration of basic proteins toward the cathode and for 
the migration of small proteins through the substrate 
contacting the gel. 
All immunoblotting operations were conducted at 
room temperature. PVDF blots were blocked in TBST 
[ 10 mM Tris-HCl, pH 7.6, 137 mM NaCl, 0.1% poly- 
oxyethylene sorbitan monolaurate (Tween 20)] plus 5% 
nonfat dry milk for 1 h. Blots were incubated 30 min in 
a rabbit IgG prepared against human MBP (Accurate 
Chemical and Scientific Corporation, Westbury, NY, 
AXL746) diluted 1 : 500 in TBST. Primary antibody 
was washed with two brief changes 25 ml TBST, a 1.5 
min wash and two 5 min washes of the same. The 
secondary antibody incubation was for 30 min in a 
1: 1000 dilution (TBST) of biotinylated goat anti rabbit 
IgG (Vector Laboratories BA-1000, Burlingame, CA). 
Secondary antibody was washed as described for pri- 
mary. During this wash the avidin/HRP (horse radish 
peroxidase) complex was preincubated as per manufac- 
turers instructions (Vector Laboratories PK-4000) with 
the exception that the dilution was increased to 10 ~1 
avidin (reagent A) : 10 ~1 biotinylated HRP : 3 ml TBST. 
Incubation time in this solution was 30 min. Excess 
avidin/ HRP was washed with TBST plus 0.1%’ non- 
idet P-40 to reduce nonspecific avidin binding (T. Nair, 
personal communication). Wash times were as de- 
scribed above with an additional 5 min wash in TBST 
plus 0.1% nonidet P-40 and a final 5 min wash in 
TBST. HRP binding was detected by 15, 30, and 60 s 
exposures to X-ray film following a 1 min incubation in 
a chemiluminescent HRP substrate (Amersham, Ar- 
lington Heights, IL). 
To ensure that ‘IP was not interfering with detec- 
tion of chemiluminescent bands, prior to immunoblot- 
ting, blots were briefly wetted with methanol, air dried 
and used to expose X-ray film (Kodak XAR-5, 
Rochester, NY) for 4 min at room temperature. This 
short autoradiographic exposure was four times longer 
than the longest subsequent chemiluminescent expo- 
sure. This control always resulted in clear film. 
After chemiluminescent detection, HRP activity was 
abolished by washing blots briefly in TBST followed by 
a 10 min incubation in 1 ml 30% hydrogen peroxide: 2 
ml TBST. To confirm the loss of HRP activity and 
chemiluminescent substrate, blots were then exposed 
to X-ray film for four min. This control always resulted 
in clear film. 
For detection of radiolabeled proteins, blots were 
briefly wetted in methanol, air dried and exposed to 
X-ray film for autoradiography for 16 h at -70°C 
sandwiched between two intensifying screens (DuPont 
Cronex Lightning Plus, Wilmington, DE). 
The following landmarks were used for a careful 
alignment of immunoblot and autoradiographic im- 
ages. For the longer chemiluminescent exposures the 
edge of the PVDF substrate was clearly visible as a 
crisp line. To establish landmarks for aligning autora- 
diographs, blots were firmly taped to the X-ray film 
and a dissection pin was used to pierce the blot and the 
film at three corners. After exposing and developing 
the film, the pin holes in the blot and film were 
realigned on a light box and the edges of the blot were 
carefully etched on the film. This etched perimeter 
superimposed precisely with the outline of the edges of 
the blot on chemiluminescent images. 
To further check against cross contamination, au- 
toradiographs were compared to chemiluminescent 
films. The most intense autoradiographic band (29 
kDa) was never detected as a chemiluminescent band. 
Conversely, the most intense chemiluminescent bands 
(the biotinylated molecular weight standards) were 
never detected on the autoradiograph. These internal 
controls confirmed that autoradiographic protein bands 
were a result of only the 32P label and that chemilumi- 
nescent bands were a result of only antibody binding. 
This procedure has proven to be superior to double 
labeling protocols which involve waiting for the 32P 
label to decay before proceeding with immunoblotting 
steps for two reasons. First, it eliminates weeks to 
months of waiting for a result and, second, it elimi- 
nates the risk of epitope denaturation during the wait- 
ing period. 
2.9. Animal use and care 
The care and use of the animals for this project 
were approved by the University Committee on Use 
Table 1 
~81 and p12 phosphorylation in response to second messengers 
Addition Phosphate incorporation 
(% of control) 
P81 n P12 n 
CaM * 68.6 f 4.4 5 * 67.2 + 10.4 5 
cGMP 106.4 + 8.2 7 107..5* 8.6 6 
CAMP 109.4k5.4 7 113.3* 7.0 7 
lipids 113.5 + 9.6 6 137.2 + 28.2 6 
Tissue homogenates from the auditory nerve were assayed for en- 
dogenous kinase activity as described in Materials and methods. 
Phosphate incorporation relative to controls (0.6 mM CaCI, only) 
are given as meansfs.e.m. for additions of 0.6 mM CaCl, plus 10 
PM calmodulin (CaM), 1 PM cGMP, 1 PM CAMP, or lipids 0lO 
kg/ml phosphatidylserine, 10 pg/ml diolein). Asterisk indicates 
significant difference from control, P < 0.02. 




Fig. 1. A calcium/calmodulin-dependent block in phosphorylation of 
~81 and p12 is antagonized by trifluoperazine in homogenates from 
the distal portion of the auditory nerve and spiral ganglion. Tissue 
was prepared as described in text for endogenous kinase assays. 
Labeling was conducted in the presence of 0.2 mM EGTA for each 
condition with the following additions: lane 1, homogenization buffer 
only; lane 2, 0.6 mM CaCl,; lane 3, 0.6 mM CaCl, plus 10 NM 
bovine cahnodulin; lane 4 calcium and calmoduhn as lane 3 plus 30 
WM trifhroperazine. Autoradiograms are shown after separation of 
proteins by SDS-PAGE. 
and Care of Animals, the University of Michigan for 
NIH program project grant DC-00078 Perception and 
Processing’of Complex Biological Signals. 
3. Results 
3.1. Calcium /calmodulin-dependent phosphorylation 
In the presence of low calcium (0.2 mM EGTA), the 
phosphoproteins most prominently labeled by [ y3’P] 
ATP had molecular weights of 29, 28, 12, 17 and 81 
kDa, in descending order of 32P incorporation. Addi- 
tion of calcium and calmodulin did not change the 
phosphorylation of the 29 and 28 kDa proteins. 
32P incorporation into ~81 and ~12, however, was 
significantly reduced (31.4 and 32.8%, respectively, P 
< 0.02, Table 1) in response to added calcium and 
calmodulin (Fig. 1, lanes 2 and 3 compared to lanes 1). 
In contrast, under the same conditions, addition of 
other second messengers (CAMP, cGMP and lipids) 
produced no significant changes in phosphorylation in 
these two proteins (Table 1). 
The calmodulin-dependent reduction of 32P incor- 
poration into p81 and p12 was partially blocked by the 
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concurrent addition of the calmodulin antagonist triflu- 
operazine as evidenced by an increase in intensity of 
the ~81 and ~12 bands on autoradiographs (Fig. 1, lane 
4 Compared to lane 3). The reduction and its antago- 
nism by trifluoperazine was also observed in prepara- 
tions of the nerve fiber core removed from the bony 
modiolus (data not shown). 
In four of six experiments, the response to added 
calcium, calmodulin and trifluoperazine of a ~17 phos- 
phoprotein mimicked that of p81 and ~12, suggesting 
all three may be regulated by a similar mechanism. 
However, labeling of ~17 was inconsistent and could 
not always be detected. Thus, further statistical analy- 
sis of the regulation of this protein by calcium and 
calmodulin must await determination of appropriate 
reaction conditions. 
3.2. Calcium / calmodulin-independent dephosphoryla - 
tion 
Calcium and calmodulin could be exerting their 
effects by stimulating a phosphatase or a protease. To 
test these possibilities, dephosphorylation was mea- 
sured in a chase assay. Here, proteins are labeled with 
radioactive ATP for a brief period; then labeling is 
essentially halted by addition of excess nonradioactive 
ATP. The ensuing loss of ‘*P label in proteins is an 
indication of either proteolysis or dephosphorylation. 
To establish the optimal time interval for determining 
I 
10 20 30 
time (min) 
Fig 2. Time courses for dephosphorylation of ~81 and ~12. Aliquots 
of auditory nerve homogenate were labeled in low calcium condi- 
tions. After 30 s the ‘chase’ was initiated by addition of unlabeled 
ATP, CaCI, and bovine calmodulin as described in text. For the 0 
time point, ‘stop buffer’ was included in the additions followed 
immediately by boiling. For the other time points, dephosphorylation 
was allowed to proceed in the presence of unlabeled ATP, calcium 
and calmodulin before the addition of ‘stop buffer’ and boiling. ‘*P 
incorporation was measured in bands cut from dried gels. Dephos- 
phorylation of pgl and p12 is plotted as the percent of radioactivity 
at time 0 (initiation of the ‘chase’). Values are means S.E.M. n = 3. 
EGTA Ca++ Ca++/CaM Ca++/TFP 
Fig. 3. Effects of calcium, calmodulin and antagonist trifluoperazine 
on dephosphorylation of ~81 and ~12. Chase assays were conducted 
as described in the legend for figure 2 except reactions were stopped 
after 5 min. Relative rate of dephosphorylation is plotted as the 
percentage loss of s2P at 5 min compared to a paired control sample 
stopped with simultaneous addition of SDS and unlabeled ATP after 
the 30 s labeling period. Additions during the chase period are given 
in Experimental Procedure and indicated as abscissa labels in the 
figure. A high% loss indicates high phosphatase activity. 
rates of dephosphorylation. we first measured the time 
course of loss of j2P label in ~81 and ~12 with calcium 
and calmodulin present during the chase period (Fig. 
2). Potential proteolysis was additionally limited by 
reducing the labeling period from 15 min to 30 s. Both 
p81 and ~12 incorporated sufficient ‘lP (256 + 26 and 
3000 + 208 cpm/mg total protein, respectively, n = 32) 
during the 30 s labeling period to ahow subsequent 
measurement of loss of label. Following the addition of 
unlabeled ATP, a time-dependent reduction in “P 
content was observed in all auditory nerve phosphopro- 
teins resolved by SDS-PAGE. There was no increase in 
72P incorporation in lower molecular weight proteins 
during this period indicating an absence of calcium-de- 
pendent protease activity. With calcium and calmod- 
ulin added during the chase period, the rate of loss of 
label of ~81 and p12 was greatest during the initial 5 
min (Fig. 2). 
Consequently, we used five min as the optimal time 
interval for subsequent chase assays testing the effects 
of calcium and calmodulin on the rates of dephospho- 
rylation of p81 and ~12 (Fig. 3). Here, a higher %I loss 
of 32P incorporation from initial values after a 5 min 
chase corresponds to an increased rate of dephospho- 
rylation, ie. increased phosphatase activity. 
The addition of calcium and calmodulin produced a 
trend toward decreasing phosphatase activity (Fig. 3 
Ca2+ and Ca2+/calmodulin vs. EGTA). For ~12, the 
presence of calcium plus calmodulin resulted in signifi- 
cantly lower rates of dephosphorylation (P < 0.02). 
Furthermore, addition of calcium and trifluoperazine 
during the chase period (Fig. 3, Ca’+/trifluoperazine) 
apparently reversed the calcium effect. 
3.3. Determination of phosphoamino acids in p 12 
The majority of “P incorporation was detected as 
phosphoserine with a trace amount of phosphothreo- 
nine. Relative ratios of phosphoserine : phosphothreo- 
nine : inorganic phosphate (a hydrolysis product of 
phosphoamino acids) determined by densitometry were 
100 : 3 : 21 and 100 : 2 : 170 for 1.5 and 5.5 h of hydroly- 
sis, respectively. No phosphotyrosine was detected af- 
ter extensive autoradiographic exposure (10 d, double 
intensifying screens, - 70”). With these conditions, 
background levels on the autoradiographs in the region 
of the phosphotyrosine standard were one order of 
magnitude below the phosphothreonine signal for a 
spot of equal area. Several additional spots containing 
32P migrated only in the second dimension (chromatog- 
raphy) but not in the first (electrophoresis). ‘*P content 
of these spots was reduced by increased hydrolysis time 
consistent with the expected behavior of incompletely 
hydrolyzed peptide fragments. 
3.4. Iden tifcation of p81 
Antiserum against MARCKS (Albert et al., 1984) 
recognized 81 kDa phosphoproteins in both spiral gan- 
1 2 3 4 5 6 
48 
12- 
Fig. 4. ~81 is immunoprecipitated by antiserum prepared against 
MARCKS. Homogenates from auditory nerve (lanes l-4) and brain 
(lanes 5 and 6) were labeled in the absence (odd numbered lanes) or 
presence (even numbered lanes) of calcium and bovine calmodulin as 
described in text. Phosphoproteins are visualized as bands on an 
autoradiograms. ~81 is identified from whole tissue samples (lanes 1 
and 2) by its characteristic calcium/calmodulin-dependent reduction 
in jzP incorporation. Antiserum against MARCKS precipitated an 
81 kDa protein from both tissues (lanes 3-6). 
la 2a lb 2b 
122 - 
74 - 
Fig. 5. ~12 is distinct from myelin basic protein. Modiolar ho- 
mogenates were prepared as described in Methods. Proteins from 
the same blot are labeled by both chemiluminescrnce with antibodies 
against myelin basic protein (lanes la and 2a) and by “P autoradio- 
graphy (lanes lb and 2b). The sample for lanes la and b was labeled 
in low calcium (0.2 mM EGTA) while that for lanes 2a and b was 
labeled in the presence of added calcium (0.6 mM CaCi,) and 
calmodulin (10 PM). p12 is indicated by the 12.3 kDa band. Myelin 
basic protein (MBP) isoforms are indicated by the bracket ( 12.5 to 22 
kDa). Other proteins indicated are visualized (24, 74 and 122 kDa1 as 
a result of nonspecific binding of biotinylated secondary antibody 
and avidin. 
glia and brain with a high degree of specificity (Fig. 4, 
lanes 3-6). The immunoprecipitated proteins comi- 
grated with p81 from untreated auditory nerve tissue. 
The latter was identified by its characteristic calcium/ 
calmodulin-dependent reduction in ‘*P incorporation 
(Fig. 4, lanes 1 and 2). The 81 kDa protein precipitated 
from auditory nerve also exhibited this reduction (Fig. 
4, lanes 3 and 4) while that from brain did not (Fig. 4, 
lanes 5 and 6). 
A 48 kDa phosphoprotein was also precipitated by 
the MARCKS antiserum from auditory nerve and brain. 
These bands appeared only in the immunoprecipitate 
from auditory nerve labeled in low caIcium (Fig. 4, lane 
3) and in that from brain labeled in high calcium and 
calmodufin (Fig. 4, lane 6). They are further character- 
ized by a concave downward shape for the former and 
a concave upward shape for the latter. The significance 
of these observations is undetermined but may indicate 
limited proteolysis or the presence of MARCKS homo- 
logues or MARCKS-binding phosphoprotein(s). Other 
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minor phosphoproteins observed in the immunoprecip- 
itate had mobilities corresponding to those that non- 
specifically bound to S. aureus cells in the preclearing 
step. Under the same conditions, normal rabbit serum 
failed to precipitate phosphoproteins from either tis- 
sue. 
3.5. Comparison of pl2 to MBP 
In order to ascertain whether p12 is distinct from 
the 14 kDa MBP a double labeling procedure was 
employed. In these experiments “P-labeled modiolar 
proteins were transferred to a solid substrate which 
was probed with polyclonal antibodies against MBP 
and processed for autoradiography as described in 
Methods. p12 was clearly resolved from any proteins 
recognized by antibodies against MBP. p12 (12.3 kDa) 
was clearly identified in the autoradiograph by its 
diminished ‘*P incorporation in the presence of cal- 
cium and calmodulin (Fig. 5, lanes lb vs. 2b, respec- 
tively). Protein bands at 22, 20, 18, 17, 14, and 12.5 kDa 
were specifically recognized by antibodies against MBP 
(Fig. 5, lanes la and 2a, MBP). The first four of these, 
22-14 kDa correspond to the known molecular weights 
of MBP (Martenson, 1992). A 12.5 kDa MBP has not 
been described for mammalian nervous tissue. Control 
experiments suggested that the 12.5 kDa protein band 
is a proteolytic fragment that results from hydrolysis of 
the 14 kDa MBP. When tissue was incubated at a 
lower temperature (000 over a shorter period of time 
(10 min) before analysis by SDS-PAGE and im- 
munoblotting the 14 kDa chemiluminescent band was 
more intense than that shown in Fig. 5 and the 12.5 
kDa band was not detectable. Additional nonspecific 
bands in Fig. 5 at 122, 74 and 24 kDa were also 
detected in controls in the absence of primary anti- 
body. 
3.6. Tissue distribution of ~12 
We have surveyed a number of tissues for the pres- 
ence of ~12 [heart, brain, liver, kidney, cochlear sen- 
sory epithelium and lateral wall (Coling and Schacht, 
1991); sciatic and optic nerves, vestibular ganglion and 
nerve (this study)]. Cranial nerve VIII is the only tissue 
of those tested where we have detected a 12 kDa 
phosphoprotein whose “P incorporation is blocked by 
calcium and calmodulin. 
4. Discussion 
The only mechanism that can account for the inhibi- 
tion of phosphorylation of p12 and ~81 in auditory 
nerve (Fig. 1) is a calmodulin-dependent block of pro- 
tein kinase activity. This type of regulation has been 
demonstrated for the phosphorylation of MARCKS by 
protein kinase C in other systems (Graff et al., 1989). 
This mechanism has been suggested for only four other 
proteins: neuromodulin (Houbre et al., 1991), neuro- 
granin (Baudier et al., 19911, MBP (Grand and Perry, 
1980) and a 200 amino acid protein whose cDNA 
contains a domain highly homologous with the phos- 
phorylation sites and calmodulin-binding domain of 
MARCKS (Umekage and Kato, 1991). 
Alternative models for the calmodulin-dependent 
decrease of phosphorylation of p12 and ~81 involve 
stimulation of phosphatase or protease activity by 
calmodulin. These models are ruled out by the experi- 
mental evidence. Either mechanism predicts calcium 
and calmodulin will stimulate the rate of loss of “P 
during chase experiments. In fact, our results show the 
opposite. Dephosphorylation of ~12 was significantly 
inhibited by calcium and calmodulin (Fig. 3). Dephos- 
phorylation of ~81 followed the same trend. These 
results indicate that the lower rate of phosphorylation 
in the presence of calmodulin (Fig. 1) cannot be due to 
the stimulation of either a protein phosphatase 
(calcineurin, protein phosphatase 2B) or a protease. 
The inhibition of dephosphorylation of p12 and ~81 
by calmodulin (Fig. 3) could be indirect through 
calmodulin-dependent activation of inhibitors of pro- 
tein phosphatases 1 or 2A (Cohen, 1989). Alternatively, 
it could be mediated by binding of calmodulin to a 
domain close to the phosphorylation sites of p12 and 
p81 blocking both phosphorylation and dephosphoryla- 
tion. Calmodulin appears to inhibit phosphorylation of 
MARCKS by this mechanism (Graff et al., 1989; Toku- 
mitsu et al., 1989). 
We have identified ~81 as MARCKS by immuno- 
precipitation. Regulation of phosphorylation and de- 
phosphorylation of p12 mimics that of MARCKS. We 
suggest that ~12, a major phosphoprotein of the audi- 
tory nerve, is a new member of the family of proteins 
whose phosphorylation is regulated by the same mech- 
anism. Since we have only detected p12 in tissue from 
cranial nerve VIII, it seems reasonable to adopt the 
tentative hypothesis that either p12 or p12 kinase may 
be specific to the inner ear or at least an abundant 
marker protein for this tissue. 
It is unlikely that p12 is a proteolytic product of 
MARCKS. If this were the case, “P incorporated in 
p12 should increase during the chase when in fact it 
did not. Additionally, p12 is not recognized by poly- 
clonal antiserum raised against MARCKS. These data 
are consistent with the hypothesis that p12 is a distinct 
kinase substrate and not a proteolytic fragment derived 
from MARCKS or from some other phosphoprotein of 
higher molecular weight. 
Neurogranin is a neuronal protein of molecular 
weight close to that of ~12. Phosphorylation of neuro- 
granin is also calmodulin-dependent. but appears to 
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have opposite calcium sensitivity as that of p12 (Baudier 
et al., 1991). Thus, identity is unlikely. 
Phosphorylation of MBP, on the other hand, is 
similar to that of ~12. MBP is also a substrate for 
calcium-independent kinases (Nairn et al., 1985). As in 
the case of ~12, phosphorylation of MBP is blocked by 
calcium and calmodulin (Grand and Perry, 19801. The 
distal portion of the auditory nerve which constitutes 
the bulk of the tissue in our preparation contains 
abundant amounts of myelin. We have observed that 
both p12 and the calcium-independent p12 kinase par- 
tition in a particulate fraction (Coling and Schacht, 
unpublished observation) as expected for myelin pro- 
teins. Although the apparent molecular weight of p12 
does not correspond to that of the many known post- 
transcriptional variants of MBP (Martenson, 1992; 
Greenfield et al., 1982), it needs to be considered that 
p12 may be a novel tissue-specific MBP. This, however, 
remains a formal possibility only. Different molecular 
weight MBP translation products result from alterna- 
tive splicing of the primary RNA transcript. Splicing 
out exons 2, 5 and 6, a type of processing that has not 
been reported in mammals, would result in a protein 
with a predicted molecular weight close to that of ~12 
(Martenson, 1992). This hypothesis, however, places 
restrictions on the distribution of the antigenic epi- 
topes. The fact that p12 is not recognized by the 
polyclonal anti-MBP used in this study (Fig. 5), re- 
quires that all of the antigenic epitopes recognized be 
restricted to exons 2, 5, and 6. Thus, until sequence 
data is available, the working hypothesis that p12 is 
distinct from MBP seems more likely. 
Analysis of phosphoamino acids of p12 indicates 
that ~12 kinase is a member of the serine/ threonine 
kinase family. The predominant phosphorylation in- 
volves modification of serine. Although the detection 
of phosphothreonine is intriguing owing to the relative 
infrequency of threonine phosphorylation (Nairn, 19851, 
it is possible that the threonine phosphorylation we 
detected was either from a nonstoichiometric phospho- 
rylation of p12 or from a minor protein that comi- 
grated with ~12. 
Clues to the function of p12 and ~81 may be found 
by understanding their regulation. Calmodulin-depen- 
dent inhibition of protein phosphorylation is rare. Our 
interest in ~12 and in p81 (MARCKS) is motivated not 
only by the possibility that ~12, ~12 kinase or ~81 
kinase may be specific to the auditory system, but also 
by the relatively novel nature of the inhibitory mecha- 
nism. 
The function of the proteins regulated by this mech- 
anism is not yet well established. However, the emerg- 
ing role of MARCKS in remodeling of the cortical 
cytoskeleton is fascinating. MARCKS is an actin 
bundling protein that can translocate from plasma 
membrane to cytosol. These processes are intricately 
regulated by calmodulin and protein phosphorylation. 
Phosphorylation appears to mediate translocation from 
membrane to cytosol; calmodulin inhibits both phos- 
phorylation of MARCKS and its binding to actin (Graff 
et al., 1989; Thelen et al., 1991; Hartwig et al., 1993). 
The results of the present study (Fig. 31 raise the 
possibility that calmodulin may also inhibit dephospho- 
rylation. The balance of these regulatory mechanisms 
would provide a means of controlling interactions of 
the plasma membrane and the cytoskeletal lattice. 
Two differences in the phosphorylation of MAR- 
CKS in auditory nerve compared to brain may provide 
clues for specializations specific to the inner ear. First, 
32P-incorporation in MARCKS (per mg total protein) 
is much higher in the auditory nerve than in cerebral 
cortex under conditions of low calcium. This difference 
is consistent with either a higher abundance of MAR- 
CKS or a higher activity of its kinase in auditory nerve. 
MARCKS phosphorylation is generally associated with 
protein kinase C (PKC) activity (Wu et al.. 1982; 
Hartwig et al., 1992). It has been proposed that myelin 
fractions may contain a specific proteolytic fragment of 
PKC that is catalytically active without calcium (Nairn, 
1985). This possibility may also account for the failure 
of PKC activators (diacylglyceride and phosphatidylser- 
ine) to stimulate the phosphorylation of either ~12 or 
~81. Second, the pronounced calmodulin-dependent 
inhibition of phosphorylation of MARCKS was seen in 
homogenates of auditory nerve but not brain. This type 
of inhibition of MARCKS phosphorylation has so far 
only been reported in subcellular fractions such as 
synaptosomes (Albert et al., 1984) and in reconstituted 
enzyme systems (Graff et al., 1989; Tokumitsu et al.. 
1989). The differences between auditory nerve and 
brain may be due to several factors, including a tissue- 
specific protein kinase or, conceivably, an auditory- 
specific MARCKS isoform. This information coupled 
with future experiments on the localization of p12 and 
MARCKS in the cochlea and auditory nerve should 
provide some useful insights on the role of these pro- 
teins in the regulation of cellular physiology in the 
inner ear. 
Acknowledgements 
The authors wish to thank Drs. T. Ueda and C. 
Bovenkerk for advice and assistance with phospho- 
amino acid analysis and Drs. A. Nairn, K. Albert, 
J.K.-T. Wang and P. Greengard for sharing recent data 
on the MARCKS protein and for a generous gift of 
antiserum. We also thank S. Crann, J. Fessenden and 
Dr. G. Tennekoon for valuable comments on the 
manuscript. The work was supported by the NIH pro- 
gram project grant DC-00078 and training grant DC- 
00011. 
References 
Albert, K.A.. Wu, WCS., Nairn. A.C.. Grcengard. P. (lYK4) Inhibi- 
tion by calmodulin of calcium/phospholipid-dependent protein 
phosphorylation. Proc. Nat]. Acad. Sci. USA 81. 3622-3625. 
ALbert, K.A., Walaas. S.I., Wang, J.K.-T. and Greengard, P. (1YXh) 
Widespread occurrence of “87 kDa,” a major specific substrate 
fog protein kin,lse C. Proc. Natl. Acad. Sci. USA 83. 2822~21326. 
Baudiel. J.. Delouhne. J.C., Van Dorsselarrr, A., Black, D. and 
Matthes, H.W.D (1991) Purification and characterizalion of a 
brain-specific protein kinasr C substrate, neurogramn (~17). J. 
Rio\. Chrm. 266, 229%117 
Cohen, P. (19x9) The structure and regulation of protein phos- 
phatases. Ann. Rev. Biochrm. 5X. 353~508. 
Cohen, P. and I&e. C.B. ( 1988) Calmodulin, Elsevier. Amsterdam. 
Colmg. D.E. and Schacht, J (1991) Protein phosphorylatiun in the 
organ of Corti: Differential regulation by second messengers 
hctwrcn bax ;Ind apex. Hear. Res. 57. 11.1-120. 
DuPont, J.. Guilhaume. A. and Arm, J-M. (lY93) Neuronal degener- 
ation of primary cochlear and vestlhular innervations after local 
injection of sihomicin in the guinea pug. Hear. Rrts. 6X. 217-778. 
Gratt. J.M.. Young. ‘TN, Johnson. D. and Blacksheal. P.J. (1980) 
Phofipho~vlarion-rcyulatcd calmodulin binding to a prominent 
cellular suhhtratc for protein kinasr C.J. Biol. Chem. 2&t. 2IKIX- 
11823. 
Grand. K.J.A. and Perry, S.V. (lYHQ1 The hinding of cahnodulirl to 
myelin basrc protein and histone H2B.J. Biochem. 180. 227-210. 
Hartwig. J.H.. Thelan. M., Rosen, A.. Janmey, P.A., Nairn. AC. and 
Adercm. A. (lY92) MARCKS is an actin fiIament crosslinking 
protein regulated hy protrm kinasc C and calcium-calmodulin. 
Nature 3Sf1, 6 13-622. 
H~daka. H., Watanabe, M. and Tnkumit%u. H. (lY90) Search for the 
FunctIonal substrate proteins of protein kinases and their selsc- 
tlvc Inhibitors. In: Nishlzuka et dl. (Cds.), The Biology and 
Medidne of Signal Transduction, Raven Press. New York. pp. 
4x5-490. 
Houlxt-. I)., Duportail. G.. Deloulme. .J.C and Baudier, J. (19011 
The interactions oi the braln-specific calmodulin-binding protein 
kinas? C zuhstrate. neuromoduhn (GAP 43). with membrane 
phospholipids. J. Viol. Chcm. 766. 7121-7131. 
Lacrnmli, U.K. (1070~ Cleavage of structural proteins during the 
assembly <)f the head of hactcriophage T3. Nature 227, h80-#5. 
Lefehvre, P.P.. Van De Water. T.R.. Staeckrr, H.. Weber-. T., Gali- 
novic-Schwartz, V., Moonen. G. and Ruben, R.J. (l9Y26) Nerve 
grrwtlr Caclw stimulates neurite regeneration but not survival of 
adult auditop neurons in vitro. Acta Otolaryngol. 112, 28X-93. 
Lefehvre. P.P.. Wdwr, T.. Rigo, T.. Slaecker, H., Moonen. G. and 
Van De Water, T.R. (IYY2h) Peripheral and central target-de- 
rived trophic fxtot(s) effects on auditory neurons. Hear. Res. 5X, 
IHS -Ii).?. 
Martenson. R.F. (1902) Myrlin basic protein isoforms: Structural 
and evolutionary implications of alternat& cxon splicing. In: 
R.E. Martrn\un (Ed.), Myelin: biology and chemistry, CRC Press. 
Boca Ralon. pp. 3X7-41 1 
yclloni, t. and Pontrcmoli. S, (1980) The calnams. Trends Neurosci. 
12, 438-444. 
Muslillo, P. (1984) Auditory dehcjt:, In multiple sclerosis: a review. 
Audiology 2.3. l4S- 164. 
Nairn. A.C.. Hemmings, H.C. and Greengard. P (IYXS) i’roteln 
kinasrs in the brain. Ann Rev Biochem. SJ. 431-97h. 
Nestler. E.J. and Grccngard P. (IYKO) Dopamine and depolarizing 
agents regulate the state of phosphorylation of protein I in the 
mammallan superior cervical sympathetic ganglion. Proc. Nat!. 
Acad. Sci. USA 77, 747%7483. 
Nestler, E.J. and Grccngard P. (1983) Protem Phosphorylation in the 
Nervuuh System, John Wiley and Soni. New York. 
Schwartz. A.M. (IOXh) Auditory ncrvc and sp~r;ti ganglion cells, 
Morphology and organization. In: R.,4. Altschuler. R.P. Bobbin 
and D.W. Hoffman (Ed%). Neurobiology of f learing: The Cochlea. 
Raven Press. New York. pp. 271-281 
Sm:th P.K.. Krohn, R.I.. Hermun5on. G.T.. Mallia. A.K.. Gartncr. 
F.I I., Provrnzano. M.D., Fujimoto. E.K., Goeke, N 13.. Olson. 
B.J. and Klenk. D.C. (!YXS) Mcd~urcmcnt of plotcin using hicin- 
chouinic acid. <Anal. Riochem. 150. 7h-8i 
Stewart, A.A.. Ingehritsen. T.S.. Mmalan. A.. Klcc. (‘.I% imd [‘ohen. 
P ( 1%) Discovery of a Cd2 + - and c;llniodlllin-rtepcndent pro- 
tcm phosphntase: Prob,\hle IdentIty %ith calcineurin (CaM-RPH(l) 
FEBS Lett. 137. X0-84. 
Stratford, C.A.. Fisher. S.K. and Llcda. T. (10X4) Ergopeptinc-sensi- 
tive calciumdependent protein phosphor&&n bystems in the 
brain. J. Neurochcm. 42. X42-85.5. 
Thclcn, M., Rosen, A., Nairn. A.C. and Aderem, A. (1991) Repula- 
tion by phosphorylation of rtkerslhlt: acaociation of a myristoy- 
Idted protein kinasr C suhstr:lte with the plasma membrane. 
Nature 35 I. 320-322. 
Tokurmtsu. H.. Mizulani. A. Namura, S.. Watanabe. M., and Hidaka. 
II. (19x9) Purification and charactcrizatitrn of Xlk, heat ctahle 
calmodulin-bindir~~ protein from bovine brain. Biochem. Biophys. 
Rcs. Commun. lb.?. 5X1-.%X. 
Tytzll. M.. Gulley. R L.. Wenthold, R.J.. and Lasek. R.J. (1980) Fast 
;~xonal transport in audltory neurons ot the guinea pig: a rapidly 
turned-over- glycoprolrin. Prclc. Natl. Acad. Sci. I ISA 77. 3042- 
3046. 
Ilmekagc. T ;+nd Kate. K. (1991 i A mcruse brain cDNA encodes a 
novel protein with the protem kinaxe C‘ phosphorylation site 
domain common to MARCKS. FEBS Lett. 2%. 147-151. 
Wenthold. R.J. and McGarvey. M.L.. (IYX’a) Changch in rapidly 
transported protein> in the ,kuditoy nerve :iflcl hair ccl1 Itrbh. 
Brain Res. 25.1 ‘6.3 %Y. ~I I 
Wcnlhold. R... and McCia~vey. M.L. i I9X?h) Different polyprptides 
Lire r;ipidl> transported in auditorv and optic neuron. .I. Nru- 
rochrm. ?Y, 27-ii. 
Wu. WC.. W&as. S.1.. Naxn. +Z.C. and Greengard, P. IlYK2) 
I:alciumjphosphr,lipid regul,~tc~ phoaphorylation of ;I M, “X7k” 
substrate protein in brain synaptosomes Prtr hatl. hcad. Sci. 
LISA 74. 5219-525?. 
